Abstract
The human lymphoblast line MGL8 was treated with HAT and subsequently “mutagenized” with EMS (200 μg/ml) to give 15% survival, and 6-thioguanine-resistant cells were selected by cloning in soft agarose containing the drug (1 μg/ml). Eighteen sublines of independently derived resistant clones were isolated and studied in detail. One subline had a low residual HGPRT activity of about 1% of the parental cells. The HGPRT of this subline had a higher Km for PRPP, was more sensitive to heat, and was degraded faster by trypsin than the enzyme in extracts of MGL8 cells. This resistant subline and three others contained CRM levels of 1-38%, compared to the wild-type, so they probably represent true structural mutants of the HGPRT gene. All the variants maintained the karyotype of the parental line (46, XY, 6p−).
Similar content being viewed by others
Literature cited
Szybalski, W. (1964).Cold Spring Harbor Symp. Quant. Biol. 29:151–159.
Littlefield, J.W. (1964).Nature 203:1142–1144.
Sharp, J.D., Capecchi, N.E., and Capecchi, M.R. (1973).Proc. Natl. Acad. Sci. USA 70:3145–3149.
DeMars, R. (1974).Mutation Res. 24:335–364.
Siminovitch, L. (1976).Cell 7:1–11.
Moore, G.E., and McLimans, W.F. (1968).J. Theor. Biol. 20:217–226.
Sato, K., Siesinski, R.S., and Littlefield, J.W. (1972).Proc. Natl. Acad. Sci. USA 69:1244–1248.
Lever, J.E., Nuki, G., and Seegmiller, J.E. (1974).Proc. Natl. Acad. Sci. USA 71:2679–2683.
Nyoromi, O., Sinclair, J.H., and Klein, G. (1972).Exp. Cell Res. 82:241–251.
Beratis, N.G., and Hirschhorn, K. (1973).Mamm. Chromosome Newsl. 14:114–116.
Hayflick, L. (1965).Tex. Rep. Biol. Med. 23:Supp. 1, 285–303.
Schneider, E.L., Stanbridge, E.J., and Epstein, C.J. (1974).Exp. Cell Res. 84:311–318.
Lowry, O.H., Rosenbrough, N.J., Farr, A.L., and Randall, R.J. (1951).J. Biol. Chem. 193:265–275.
Kelley, W.N., and Mead, J.C. (1971).J. Biol. Chem. 246:2953–2958.
Arnold, W.J., Mead, J.C, and Kelley, W.N. (1972).J. Clin. Invest. 51:1805–1812.
Szybalski, W., Szybalska, E.H., and Ragni, G. (1962).Natl. Cancer Inst. Monagr. 7:75–89.
Littlefield, J.W. (1966).Exp. Cell Res. 41:190–196.
Albertini, R., and DeMars, R. (1970).Science 169:482–485.
Orkin, S.H., and Littlefield, J.W. (1971).Exp. Cell Res. 66:69–74.
DeMars, R., and Held, K.R. (1972).Humangenetik 16:87–110.
Albertini, R., and DeMars, R. (1973).Mutation Res. 18:199–224.
Shapiro, N.D., Khalizev, A.E., Luss, E.V., Marshak, M.I., Petrova, O.N., and Varshaver, N.B. (1972).Mutation Res. 15:203–214.
Epstein, J., and Littlefield, J.W. (1977).Exp. Cell Res. in press.
Zylka, J.M., and Plagemann, P.G.W. (1975).J. Biol. Chem. 250:5756–5767.
Capecchi, M.R., Capecchi, N.E., Hughes, S.H., and Wahl, G.M. (1974).Proc. Natl. Acad. Sci. USA 71:4732–4736.
Zielke, H.R., Hong, S., and Littlefield, J.W. (1976).Exp. Cell Res. 97:426–429.
Reem, G.H. (1975).Science 190:1098–1099.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Epstein, J., Leyva, A., Kelley, W.N. et al. Mutagen-induced diploid human lymphoblast variants containing altered hypoxanthine guanine phosphoribosyl transferase. Somat Cell Mol Genet 3, 135–148 (1977). https://doi.org/10.1007/BF01551810
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01551810